High performance liquid chromatography – Mass spectrometric bioanalytical method for the determination of dapoxetine in human plasma: Application for bioequivalence study
Authors:
- 1 July 2020
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B
- Vol. 1149, 122154
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Solid-Phase Microextraction Coupled to LC-ESI-MS/MS: Evaluation and Correction for Matrix-Induced Ionization Suppression/Enhancement for Pharmaceutical Analysis in Biological and Environmental SamplesAnalytical Chemistry, 2011
- Efficacy and Safety of Dapoxetine for the Treatment of Premature Ejaculation: Integrated Analysis of Results from Five Phase 3 TrialsThe Journal of Sexual Medicine, 2011
- Efficacy of Dapoxetine in the Treatment of Premature EjaculationClinical Medicine Insights: Reproductive Health, 2011
- Liquid–liquid extraction in flow analysis: A critical reviewAnalytica Chimica Acta, 2009
- Reply: Dapoxetine in Premature EjaculationNeuropsychopharmacology, 2008
- Dapoxetine and Paroxetine for the Treatment of Premature EjaculationClinical Neuropharmacology, 2007
- Enhanced Performance Test Mix for High-Throughput LC/MS Analysis of Pharmaceutical CompoundsJournal of Combinatorial Chemistry, 2006
- Matrix effect in LC-ESI-MS and LC-APCI-MS with off-line and on-line extraction proceduresJournal of Chromatography A, 2004
- Sample preparation methods for the analysis of pharmaceutical materialsSeparation Science and Technology, 2004
- Determination of dapoxetine, an investigational agent with the potential for treating depression, and its mono- and di-desmethyl metabolites in human plasma using column-switching high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1993